Cargando…
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia
Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Tela...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361547/ https://www.ncbi.nlm.nih.gov/pubmed/15942625 http://dx.doi.org/10.1038/sj.bjc.6602658 |
_version_ | 1782153238780313600 |
---|---|
author | Olsen, J H Hahnemann, J M D Børresen-Dale, A-L Tretli, S Kleinerman, R Sankila, R Hammarström, L Robsahm, T E Kääriäinen, H Bregård, A Brøndum-Nielsen, K Yuen, J Tucker, M |
author_facet | Olsen, J H Hahnemann, J M D Børresen-Dale, A-L Tretli, S Kleinerman, R Sankila, R Hammarström, L Robsahm, T E Kääriäinen, H Bregård, A Brøndum-Nielsen, K Yuen, J Tucker, M |
author_sort | Olsen, J H |
collection | PubMed |
description | Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1–1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2–2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8–4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3–17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity. |
format | Text |
id | pubmed-2361547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23615472009-09-10 Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia Olsen, J H Hahnemann, J M D Børresen-Dale, A-L Tretli, S Kleinerman, R Sankila, R Hammarström, L Robsahm, T E Kääriäinen, H Bregård, A Brøndum-Nielsen, K Yuen, J Tucker, M Br J Cancer Genetics and Genomics Epidemiological studies have consistently shown elevated rates of breast cancer among female blood relatives of patients with ataxia telangiectasia (AT), a rare autosomal recessive disease. A large proportion of the members of AT families are carriers of AT-causing gene mutations in ATM (Ataxia Telangiectasia Mutated), and it has been hypothesised that these otherwise healthy carriers are predisposed to breast cancer. This is an extended and enlarged follow-up study of cancer incidence in blood relatives of 75 patients with verified AT in 66 Nordic families. Blood relatives were identified through population registry linkages, and the occurrence of cancer was determined from cancer registry files in each country and compared with national incidence rates. The ATM mutation carrier probabilities of relatives were assigned from the combined information on location in family, consanguinity, if any, and supplementary carrier screening in some families. Among the 1445 blood relatives of AT patients, 225 cancers were observed, with 170.4 expected, yielding a standardised incidence ratio (SIR) of 1.3 (95% confidence interval (CI), 1.1–1.4). Invasive breast cancer occurred in 34 female relatives (SIR, 1.7; 95% CI, 1.2–2.4) and was diagnosed in 21 women before the age of 55 years (SIR, 2.9; 95% CI, 1.8–4.5), including seven mothers of probands (SIR, 8.1; 95% CI, 3.3–17). When the group of mothers was excluded, no clear relationship was observed between the allocated mutation carrier probability of each family member and the extent of breast cancer risk. We concluded that the increased risk for female breast cancer seen in 66 Nordic AT families appeared to be restricted to women under the age of 55 years and was due mainly to a very high risk in the group of mothers. The findings of breast cancer risk in mothers, but not other likely mutation carriers, in this and other studies raises questions about the hypothesis of a simple causal relationship with ATM heterozygosity. Nature Publishing Group 2005-07-25 2005-06-07 /pmc/articles/PMC2361547/ /pubmed/15942625 http://dx.doi.org/10.1038/sj.bjc.6602658 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Genetics and Genomics Olsen, J H Hahnemann, J M D Børresen-Dale, A-L Tretli, S Kleinerman, R Sankila, R Hammarström, L Robsahm, T E Kääriäinen, H Bregård, A Brøndum-Nielsen, K Yuen, J Tucker, M Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title | Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title_full | Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title_fullStr | Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title_full_unstemmed | Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title_short | Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia |
title_sort | breast and other cancers in 1445 blood relatives of 75 nordic patients with ataxia telangiectasia |
topic | Genetics and Genomics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361547/ https://www.ncbi.nlm.nih.gov/pubmed/15942625 http://dx.doi.org/10.1038/sj.bjc.6602658 |
work_keys_str_mv | AT olsenjh breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT hahnemannjmd breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT børresendaleal breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT tretlis breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT kleinermanr breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT sankilar breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT hammarstroml breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT robsahmte breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT kaariainenh breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT bregarda breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT brøndumnielsenk breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT yuenj breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia AT tuckerm breastandothercancersin1445bloodrelativesof75nordicpatientswithataxiatelangiectasia |